Hyaluronic acid treatment versus standard of care in chronic wounds in a German setting: Cost‐effectiveness analysis
Abstract Background and Aims Chronic wounds are a major burden for worldwide health care systems. In the management of chronic wounds several strategies with innovative and active agents emerged in the past few years, such as hyaluronic acid containing wound dressings. Evidence comparing the cost‐ef...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Health Science Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/hsr2.969 |
| _version_ | 1797737791139872768 |
|---|---|
| author | Dominik Blunck Prof. Dr. Oliver Schöffski |
| author_facet | Dominik Blunck Prof. Dr. Oliver Schöffski |
| author_sort | Dominik Blunck |
| collection | DOAJ |
| description | Abstract Background and Aims Chronic wounds are a major burden for worldwide health care systems. In the management of chronic wounds several strategies with innovative and active agents emerged in the past few years, such as hyaluronic acid containing wound dressings. Evidence comparing the cost‐effectiveness of hyaluronan and standard of care dressings (hydrofiber with silver) is still missing. The aim of the study is thus, to assess the cost‐effectiveness of hyaluronan versus standard of care dressings (hydrofiber with silver) in chronic wounds from a German statutory health insurance perspective. Methods A decision tree was modeled to quantify the cost and healing rate at 12 weeks for the hyaluronan and silver dressings strategies. Input parameters were collected literature‐based, accounting for healing rates, dressing prices and prices for dressing changes and associated home care. Parameter uncertainty was accounted for by one‐way and probabilistic sensitivity analysis. Results Hyaluronic acid showed a better healing rate (60.68%) and noticeable lower cost (749.80 Euro) compared to standard of care (silver containing) dressings (59.62%; 883.05 Euro), resulting in an Incremental Cost Effectiveness Ratio of −12,570.57. The hyaluronan approach is hence a dominant strategy in chronic wound management. Sensitivity analysis confirmed these results, giving a range of 60%– 70% of cost‐effective scenarios. Conclusions Hyaluronic acid dressings showed to be a clinical more effective strategy at significantly lower cost in chronic wounds compared to standard of care (hydrofiber with silver). |
| first_indexed | 2024-03-12T13:33:26Z |
| format | Article |
| id | doaj.art-8d6fe5096a864d1bb7a173ea5a585bf5 |
| institution | Directory Open Access Journal |
| issn | 2398-8835 |
| language | English |
| last_indexed | 2024-03-12T13:33:26Z |
| publishDate | 2023-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Health Science Reports |
| spelling | doaj.art-8d6fe5096a864d1bb7a173ea5a585bf52023-08-24T06:32:46ZengWileyHealth Science Reports2398-88352023-01-0161n/an/a10.1002/hsr2.969Hyaluronic acid treatment versus standard of care in chronic wounds in a German setting: Cost‐effectiveness analysisDominik Blunck0Prof. Dr. Oliver Schöffski1Department of Health Management, Institute of Management Friedrich‐Alexander‐Universität Erlangen‐Nürnberg (FAU) Nuremberg GermanyDepartment of Health Management, Institute of Management Friedrich‐Alexander‐Universität Erlangen‐Nürnberg (FAU) Nuremberg GermanyAbstract Background and Aims Chronic wounds are a major burden for worldwide health care systems. In the management of chronic wounds several strategies with innovative and active agents emerged in the past few years, such as hyaluronic acid containing wound dressings. Evidence comparing the cost‐effectiveness of hyaluronan and standard of care dressings (hydrofiber with silver) is still missing. The aim of the study is thus, to assess the cost‐effectiveness of hyaluronan versus standard of care dressings (hydrofiber with silver) in chronic wounds from a German statutory health insurance perspective. Methods A decision tree was modeled to quantify the cost and healing rate at 12 weeks for the hyaluronan and silver dressings strategies. Input parameters were collected literature‐based, accounting for healing rates, dressing prices and prices for dressing changes and associated home care. Parameter uncertainty was accounted for by one‐way and probabilistic sensitivity analysis. Results Hyaluronic acid showed a better healing rate (60.68%) and noticeable lower cost (749.80 Euro) compared to standard of care (silver containing) dressings (59.62%; 883.05 Euro), resulting in an Incremental Cost Effectiveness Ratio of −12,570.57. The hyaluronan approach is hence a dominant strategy in chronic wound management. Sensitivity analysis confirmed these results, giving a range of 60%– 70% of cost‐effective scenarios. Conclusions Hyaluronic acid dressings showed to be a clinical more effective strategy at significantly lower cost in chronic wounds compared to standard of care (hydrofiber with silver).https://doi.org/10.1002/hsr2.969chronic woundscost‐effectiveness analysisdressingshyaluronic acidsilver |
| spellingShingle | Dominik Blunck Prof. Dr. Oliver Schöffski Hyaluronic acid treatment versus standard of care in chronic wounds in a German setting: Cost‐effectiveness analysis Health Science Reports chronic wounds cost‐effectiveness analysis dressings hyaluronic acid silver |
| title | Hyaluronic acid treatment versus standard of care in chronic wounds in a German setting: Cost‐effectiveness analysis |
| title_full | Hyaluronic acid treatment versus standard of care in chronic wounds in a German setting: Cost‐effectiveness analysis |
| title_fullStr | Hyaluronic acid treatment versus standard of care in chronic wounds in a German setting: Cost‐effectiveness analysis |
| title_full_unstemmed | Hyaluronic acid treatment versus standard of care in chronic wounds in a German setting: Cost‐effectiveness analysis |
| title_short | Hyaluronic acid treatment versus standard of care in chronic wounds in a German setting: Cost‐effectiveness analysis |
| title_sort | hyaluronic acid treatment versus standard of care in chronic wounds in a german setting cost effectiveness analysis |
| topic | chronic wounds cost‐effectiveness analysis dressings hyaluronic acid silver |
| url | https://doi.org/10.1002/hsr2.969 |
| work_keys_str_mv | AT dominikblunck hyaluronicacidtreatmentversusstandardofcareinchronicwoundsinagermansettingcosteffectivenessanalysis AT profdroliverschoffski hyaluronicacidtreatmentversusstandardofcareinchronicwoundsinagermansettingcosteffectivenessanalysis |